Cargando…

Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives

Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological cancers. Despite improvements in medical treatments, the prognosis for EOC remains poor, and there is an urgent need for new therapeutic strategies. Immune checkpoint inhibitors (CPIs) have dramatically improved surviv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borella, Fulvio, Ghisoni, Eleonora, Giannone, Gaia, Cosma, Stefano, Benedetto, Chiara, Valabrega, Giorgio, Katsaros, Dionyssios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151145/ https://www.ncbi.nlm.nih.gov/pubmed/32156035 http://dx.doi.org/10.3390/diagnostics10030146

Ejemplares similares

TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers
por: Ghisoni, Eleonora, et al.
Publicado: (2019)

Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer
por: Scotto, Giulia, et al.
Publicado: (2021)

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience
por: Ghisoni, Eleonora, et al.
Publicado: (2018)

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options
por: Borella, Fulvio, et al.
Publicado: (2023)

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
por: Mittica, Gloria, et al.
Publicado: (2020)

Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity
por: Mittica, Gloria, et al.
Publicado: (2017)

Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis
por: Borella, Fulvio, et al.
Publicado: (2020)

Role of Mediterranean diet in preventing platinum based gastrointestinal toxicity in gynecolocological malignancies: A single Institution experience
por: Ghisoni, Eleonora, et al.
Publicado: (2019)

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
por: Giannone, Gaia, et al.
Publicado: (2019)

Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
por: Giannone, Gaia, et al.
Publicado: (2020)

Ovarian Cancer Immunotherapy: Turning up the Heat
por: Ghisoni, Eleonora, et al.
Publicado: (2019)

Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications
por: Giannone, Gaia, et al.
Publicado: (2019)

Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience
por: Tuninetti, Valentina, et al.
Publicado: (2020)

The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality
por: Turinetto, Margherita, et al.
Publicado: (2021)

Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells
por: Capellero, Sonia, et al.
Publicado: (2022)

From Uterus to Brain: An Update on Epidemiology, Clinical Features, and Treatment of Brain Metastases From Gestational Trophoblastic Neoplasia
por: Borella, Fulvio, et al.
Publicado: (2022)

PIK3R1(W624R) Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma
por: D’Ambrosio, Concetta, et al.
Publicado: (2020)

Update on Prognostic and Predictive Markers in Mucinous Ovarian Cancer
por: Borella, Fulvio, et al.
Publicado: (2023)

Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study
por: Calura, Enrica, et al.
Publicado: (2019)

Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review
por: Borella, Fulvio, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?
por: Mittica, Gloria, et al.
Publicado: (2016)

FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
por: Tassi, Renata A., et al.
Publicado: (2019)

Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer
por: Erriquez, Jessica, et al.
Publicado: (2016)

Affected Ovary Relative Volume: A Novel Sonographic Predictor of Ovarian Reserve in Patients with Unilateral Endometrioma—A Pilot Study
por: Cosma, Stefano, et al.
Publicado: (2020)

Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations
por: Jean, Stephanie, et al.
Publicado: (2016)

Perineural Invasion in Vulvar Squamous-Cell Carcinoma Is an Independent Risk Factor for Cancer-Specific Survival, but Not for Locoregional Recurrence: Results from a Single Tertiary Referral Center
por: Micheletti, Leonardo, et al.
Publicado: (2021)

Netrin-1 overexpression is predictive of ovarian malignancies
por: Papanastasiou, Anastasios D., et al.
Publicado: (2011)

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer
por: Capellero, S., et al.
Publicado: (2020)

PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer
por: Su, Dan, et al.
Publicado: (2012)

Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it?
por: Carosso, Andrea, et al.
Publicado: (2020)

Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
por: Turinetto, Margherita, et al.
Publicado: (2022)

Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study
por: Carosso, Andrea, et al.
Publicado: (2020)

Osteomyelitis of the pubic symphysis caused by methicillin-resistant Staphylococcus aureus after vaginal delivery: a case report and literature review
por: Cosma, Stefano, et al.
Publicado: (2019)

Androgen receptor status predicts development of brain metastases in ovarian cancers
por: Mittica, Gloria, et al.
Publicado: (2017)

Reproductive and Obstetric Outcomes Following a Natural Cycle vs. Artificial Endometrial Preparation for Frozen–Thawed Embryo Transfer: A Retrospective Cohort Study
por: Carosso, Andrea Roberto, et al.
Publicado: (2023)

Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer
por: YING, LISHA, et al.
Publicado: (2013)

Increased Placental Anti-Oxidant Response in Asymptomatic and Symptomatic COVID-19 Third-Trimester Pregnancies
por: Rolfo, Alessandro, et al.
Publicado: (2022)

Translational Research in Ovarian Cancer
por: Di Renzo, Maria Flavia, et al.
Publicado: (2020)

LncRNA ZNF582-AS1 Expression and Methylation in Breast Cancer and Its Biological and Clinical Implications
por: Wang, Junlong, et al.
Publicado: (2022)

Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters
por: Cosma, Stefano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_okthl7kk8jdgjacrv3d6qncs5e